Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,851 | 23,413 | 26,630 | 42,970 | 144,772 |
| Marketable Securities | 80,528 | 107,146 | 123,052 | 122,340 | 27,802 |
| Receivables | 8,186 | 566 | 543 | 604 | 586 |
| Other current assets | 128 | 128 | 128 | 128 | 128 |
| TOTAL | $120,268 | $132,564 | $151,812 | $168,085 | $174,757 |
| Non-Current Assets | |||||
| PPE Net | 11,462 | 6,945 | 4,086 | 3,944 | 3,242 |
| Investments And Advances | 12,601 | 12,601 | 0 | 0 | 10,099 |
| Intangibles | 123,809 | 123,809 | 358,832 | 358,832 | 515,156 |
| TOTAL | $147,872 | $143,355 | $362,918 | $362,776 | $528,497 |
| Total Assets | $268,140 | $275,919 | $514,730 | $530,861 | $703,254 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,428 | 9,910 | 7,132 | 7,753 | 7,711 |
| Other current liabilities | N/A | 107 | 297 | 308 | 722 |
| TOTAL | $10,871 | $10,585 | $8,392 | $10,084 | $11,112 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,001 | 12,001 | N/A | N/A | N/A |
| Deferred Revenues | 2,624 | 15 | 15 | 711 | 924 |
| Other Non-Current Liabilities | 10,124 | 9,065 | 8,253 | 7,993 | 7,741 |
| TOTAL | $68,171 | $62,329 | $89,713 | $89,453 | $154,065 |
| Total Liabilities | $79,042 | $72,914 | $98,105 | $99,537 | $165,177 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,025 | 55,023 | 54,842 | 54,797 | 54,626 |
| Common Shares | 870,847 | 867,393 | 864,375 | 861,148 | 840,475 |
| Retained earnings | -669,776 | -652,746 | -432,454 | -412,859 | -282,859 |
| Other shareholders' equity | -49,782 | -48,185 | -49,782 | -49,782 | -49,782 |
| TOTAL | $189,098 | $203,005 | $416,625 | $431,324 | $538,077 |
| Total Liabilities And Equity | $268,140 | $275,919 | $514,730 | $530,861 | $703,254 |